Finally, one study detected for the first time, autoantibodies targeting the cardiac voltage-gated Na+ channel (NaV1.5, SCN5A) in patients with idiopathic high-degree AV block (second-degree AV block Mobitz type II and third-degree AV block) [18]. This evidence concerns the gene SCN5A and atrioventricular block.